# reload+after+2024-01-22 16:47:37.987529
address1§27 West 24th Street
address2§Suite 702
city§New York
state§NY
zip§10010
country§United States
phone§646-481-9832
website§https://www.tourmalinebio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops TOUR006, a human monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline also comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Sandeep C. Kulkarni M.D.', 'age': 41, 'title': 'Co-Founder, CEO & Director', 'yearBorn': 1982, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ryan  Robinson CPA', 'title': 'VP of Finance, Controller & Interim CFO', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Susan Dana Jones Ph.D.', 'title': 'Chief Technology Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. W. Bradford Middlekauff J.D.', 'age': 61, 'title': 'Chief Business Officer & General Counsel', 'yearBorn': 1962, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Yung H. Chyung M.D.', 'age': 47, 'title': 'Chief Medical Officer', 'yearBorn': 1976, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ryan  Iarrobino', 'title': 'SVP of Product Development', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kevin B. Johnson M.B.A., Ph.D.', 'title': 'Chief Regulatory Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Dora  Rau', 'title': 'Senior Vice President & Head of Quality', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gerhard  Hagn Pharm.D.', 'title': 'Senior VP and Head of Commercial & Business Development', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Emil M. deGoma M.D.', 'title': 'Senior Vice President of Medical Research', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§2
payoutRatio§0.0
currency§USD
dateShortInterest§1702598400
forwardEps§-3.04
exchange§NMS
quoteType§EQUITY
shortName§Tourmaline Bio, Inc.
longName§Tourmaline Bio, Inc.
firstTradeDateEpochUtc§1620394200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f54121ba-87b6-3e2f-98f1-0816320876db
gmtOffSetMilliseconds§-18000000
targetHighPrice§65.0
targetLowPrice§41.0
targetMeanPrice§48.67
targetMedianPrice§46.5
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§6
quickRatio§17.451
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
